202 related articles for article (PubMed ID: 31478425)
1. Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis.
Zahran AM; Abdel-Rahim MH; Refaat A; Sayed M; Othman MM; Khalak LMR; Hetta HF
Acta Oncol; 2020 Jan; 59(1):33-39. PubMed ID: 31478425
[No Abstract] [Full Text] [Related]
2. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
3. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.
Ho JW; Pang RW; Lau C; Sun CK; Yu WC; Fan ST; Poon RT
Hepatology; 2006 Oct; 44(4):836-43. PubMed ID: 17006919
[TBL] [Abstract][Full Text] [Related]
4. Identification of local and circulating cancer stem cells in human liver cancer.
Yang ZF; Ngai P; Ho DW; Yu WC; Ng MN; Lau CK; Li ML; Tam KH; Lam CT; Poon RT; Fan ST
Hepatology; 2008 Mar; 47(3):919-28. PubMed ID: 18275073
[TBL] [Abstract][Full Text] [Related]
5. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study.
Fan ST; Yang ZF; Ho DW; Ng MN; Yu WC; Wong J
Ann Surg; 2011 Oct; 254(4):569-76. PubMed ID: 21892074
[TBL] [Abstract][Full Text] [Related]
6. Mobilization of Stem and Progenitor Cells in Septic Shock Patients.
Skirecki T; Mikaszewska-Sokolewicz M; Godlewska M; Dołęgowska B; Czubak J; Hoser G; Kawiak J; Zielińska-Borkowska U
Sci Rep; 2019 Mar; 9(1):3289. PubMed ID: 30824730
[TBL] [Abstract][Full Text] [Related]
7. The role of liver cancer stem cells in donor liver allocation for patients with hepatocellular carcinoma.
Zhou J; Hu Z; Li Z; Yu P; Wu J; Zheng S
Postgrad Med; 2013 Nov; 125(6):24-30. PubMed ID: 24200758
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
[TBL] [Abstract][Full Text] [Related]
9. Effect of human umbilical cord blood derived CD34
Sherif RN; Abdellatif H; Hazem N; Ebrahim NA; Saleh D; Shiha G; Eltahry H; Botros KG; Gabr OM
Tissue Cell; 2018 Feb; 50():125-132. PubMed ID: 29429512
[TBL] [Abstract][Full Text] [Related]
10. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.
Westerweel PE; Luijten RK; Hoefer IE; Koomans HA; Derksen RH; Verhaar MC
Ann Rheum Dis; 2007 Jul; 66(7):865-70. PubMed ID: 17329307
[TBL] [Abstract][Full Text] [Related]
12. An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer.
Starzyńska T; Dąbkowski K; Błogowski W; Zuba-Surma E; Budkowska M; Sałata D; Dołęgowska B; Marlicz W; Lubikowski J; Ratajczak MZ
J Cell Mol Med; 2013 Jun; 17(6):792-9. PubMed ID: 23672538
[TBL] [Abstract][Full Text] [Related]
13. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma.
Yu D; Sun X; Qiu Y; Zhou J; Wu Y; Zhuang L; Chen J; Ding Y
Clin Cancer Res; 2007 Jul; 13(13):3814-24. PubMed ID: 17606712
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
[TBL] [Abstract][Full Text] [Related]
15. CD133
Liu K; Hao M; Ouyang Y; Zheng J; Chen D
Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training.
Thijssen DH; Vos JB; Verseyden C; van Zonneveld AJ; Smits P; Sweep FC; Hopman MT; de Boer HC
Aging Cell; 2006 Dec; 5(6):495-503. PubMed ID: 17081158
[TBL] [Abstract][Full Text] [Related]
17. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
[TBL] [Abstract][Full Text] [Related]
18. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.
Pang RW; Poon RT
Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]